Related Experiment Video
Updated: Jun 5, 2026
07:23
Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
MicroRNAs in chronic lymphocytic leukemia.
Brian P Ward1, Gregory J Tsongalis, Prabhjot Kaur
1Department of Pathology, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA.
Experimental and Molecular Pathology
|December 21, 2010
Summary
MicroRNAs (miRNAs) show promise as biomarkers for chronic lymphocytic leukemia (CLL). Differences in miRNA expression in CLL patients suggest their role in disease pathogenesis and prognosis, offering new diagnostic potential.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Chronic lymphocytic leukemia (CLL) is a prevalent hematologic malignancy in Western countries.
- MicroRNAs (miRNAs), small non-coding RNAs regulating gene expression, are increasingly implicated in cancer development.
- Emerging research suggests a potential role for miRNAs in CLL pathogenesis and predicting patient outcomes.
Purpose of the Study:
- To investigate the potential of microRNAs (miRNAs) as biomarkers in chronic lymphocytic leukemia (CLL).
- To explore the differential expression of miRNAs in CLL patients compared to healthy individuals.
Main Methods:
- Analysis of miRNA expression profiles in patient samples.
- Comparison of miRNA levels between CLL patients and normal controls.
Main Results:
- Significant differences in miRNA expression were observed between CLL patients and normal individuals.
- These distinct expression patterns suggest a role for miRNAs in the molecular mechanisms underlying CLL.
Conclusions:
- MicroRNA expression levels may serve as valuable biomarkers for diagnosing and potentially prognosing chronic lymphocytic leukemia (CLL).
- Further research into miRNAs could lead to novel therapeutic strategies for CLL.
Related Concept Videos
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...